Research ID
hum0055-v1Release info
Research title
Genetic and epigentic analysis of non-alcoholic fatty liver disease
Research overview
- Aims
- To elucidate the mRNA expression related to the development and/or progression of non-alcoholic fatty liver disease (NAFLD).
- Methods
- RNA-seq and Methylation array analysis by using of mRNA or DNA purified from liver tissues
- Participants/materials
- 64 NAFLD patients
- URL
- N/A
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000059 | NGS (RNA-seq) Methylation array |
| Controlled-access (Type I) | 2020-09-28 |
Data provider
- Principal investigator
- Kikuko Hotta
- Affiliation
- Department of Medical Innovation, Osaka University Hospital
Research projects
No research projects.
Grants
| Name | Title | Project number |
|---|---|---|
KAKENHI Grant-in-Aid for Scientific Research (C) | Genetic predisposition and environmental factor retrieval of ectopic fat accumulation and their verification in prospective follow-up survey |
|
KAKENHI Grant-in-Aid for Scientific Research (C) | Elucidation of pathology and development of diagnosis method of nonalcoholic fatty liver disease by using genomic, and epigenomic analysis |
|
KAKENHI Grant-in-Aid for Scientific Research (C) | Analysis of genetic predisposition and environmental factors related to the onset and progression of nonalcoholic fatty liver disease |
|
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
Identification of core gene networks and hub genes associated with progression of nonalcoholic fatty liver disease by RNA sequencing | ||
Identification of the genomic region under epigenetic regulation during nonalcoholic fatty liver disease progression. |
Controlled access users
| Principal investigator | Affiliation | Country/Region | Research title | Period of data use | Dataset ID |
|---|---|---|---|---|---|
| Pablo Giraudi | Fondazione Italiana Fegato (ONLUS) | Italy | Meta-analysis of omics data on non-alcoholic fatty liver disease. Implications for the improvement of an in silico strategy for biomarkers discovery on liver fibrosis | 2018-12-18 – 2021-02-08 | |
| Masanori Nojima | The Institute of Medical Science, The University of Tokyo | Japan | Genome-wide DNA methylation analysis for the development of prediction model for subsequent hepato-cellular carcinoma in non-alcoholic fatty liver disease patients | 2019-01-21 – 2022-03-28 | |
| Robert Tsai | Institute of Biosciences & Technology, Texas A&M Health Science Center | Texas, United States | Genome-wide Discovery of new Plasma DNA Methylation Markers for Tracking the Progression of NAFLD to NASH and HCC | 2020-11-09 – 2023-07-25 | |
| Kikuko Hotta | Laboratory of Pathophysiology and Pharmacotherapeutics Faculty of Pharmacy, Osaka Ohtani University | Japan | Genomic and epigenomic analysis of liver disease (nonalcoholic fatty liver disease, virus hepatitis, alcoholic hepatitis, cirrhosis, and hepatocellular carcinoma) | 2021-11-11 – 2023-04-05 | |
| Michiaki Hamada | Hamada Laboratory, Faculty of Science and Engineering, Waseda University | Japan | Construction of RNA-targeted Drug Discovery Database | 2023-01-05 – 2027-10-31 |